IRS 990 Nonprofit Profile
Oxfendazole Development Group
Research and development of pharmaceutical treatments to help eliminate neglected tropical diseases especially oxfendazole through nonclinical work and the conduct of clinical studies
- Filing year
- 2024
- Total revenue
- $23K
- Total expenses
- $852K
- Program expenses
- $850K
- Administration
- $2K
- Fundraising
- $0
- Program share of expenses
- 100%
- EIN
- 811547477
- Location
- Blue Bell, PA
https: oxfendazoledevelopmentgroup.org
About CharitySense
CharitySense provides live, independent intelligence from the charitable infrastructure you fund — hospitals, schools, orphanages, and clinics anywhere in the world.
See live projects or read our insights on nonprofit accountability.
Financial data on this page is sourced from IRS Form 990 filings.